PLEASE NOTE: This course was retired on 11 Jun 2020. This means it is no longer being updated or maintained, so information within the course may no longer be accurate. FutureLearn accepts no liability for any loss or damage arising as a result of use or reliance on this information.
© Shutterstock
Patient impact: a lung cancer patient's story
In the downloadable file at the bottom of this step, a lung cancer patient explains the impact of anti-PD-1 therapy on her disease.
This is an excerpt from a statement given by a patient who underwent checkpoint blocakde (anti-PD-1) therapy at the Queen Elizabeth Hospital Birmingham, under the care of Prof Gary Middleton. Since this statement was given, a subsequent scan has confirmed that the patient is still in complete remission.
© Cancer Immunology and Immunotherapy Centre, University of Birmingham
